Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pluristem Gains Most in 17 Months on Stem-Cell Study
Bloomberg
Tuesday, January 21, 2014 - 8:25am
tags:
Pluristem, stem cells, PLX-PAD, muscle injuries
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry
Seeking Alpha
Tuesday, January 21, 2014 - 8:14am
tags:
earnings, United Therapeutics, Celgene, Regeneron, Biogen Idec, Acorda Therapeutics, Amgen, Gilead Sciences
Amarin says FDA won't reinstate special protocol assessment for ANCHOR study
First Word Pharma
Tuesday, January 21, 2014 - 8:12am
tags:
FDA, Amarin, Vascepa
VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (Avanafil)
Yahoo
Tuesday, January 21, 2014 - 8:10am
tags:
erectile dysfunction, Vivus, Auxilium, Stendra, FDA
Forest lifts earnings guidance as Q3 sales climb on newer products; posts profit
First Word Pharma
Tuesday, January 21, 2014 - 8:09am
tags:
earnings, Forest Labs
Johnson & Johnson beats fourth-quarter forecasts as drug sales shine
Yahoo/Reuters
Tuesday, January 21, 2014 - 8:08am
tags:
JNJ, earnings
Roche Schizophrenia Drug at Risk After Failing in Trials
Bloomberg
Tuesday, January 21, 2014 - 7:51am
tags:
schizophrenia, Roche, bitopertin
NuPathe accepts Teva's takeover offer, ends deal with Endo
Yahoo/Reuters
Tuesday, January 21, 2014 - 7:49am
tags:
Teva Pharmaceuticals, Endo Health Solutions, NuPathe, earnings
Novartis to shuffle jobs to support product launches
Yahoo/Reuters
Tuesday, January 21, 2014 - 7:14am
tags:
Novartis, layoffs, reorganization
Positive Oncology News Lifts OncoMed
Yahoo/Zacks.com
Monday, January 20, 2014 - 7:00pm
tags:
OncoMed, OMP-59R5, demcizumab, pancreatic cancer
The Psoriatic Arthritis Race: Celgene Vs. Johnson & Johnson
Seeking Alpha
Monday, January 20, 2014 - 3:08pm
tags:
psoriatic arthritis, Celgene, JNJ, Otezla, Stelara, apremilast
Cardialen raises $2.5 million in an equity round for its low-energy atrial fibrillation treatment
Mass Device
Monday, January 20, 2014 - 3:07pm
tags:
Cardialen, atrial fibrillation, cardiac implants, devices
Veran raises nearly $3M for 3d airway mapping system
Mass Device
Monday, January 20, 2014 - 3:04pm
tags:
Veran, devices, SPiNDrive, pulmonary nodules
Avantis raises $5M in debt round for Third Eye endoscope
Mass Device
Monday, January 20, 2014 - 2:55pm
tags:
Avantis Medical Systems, endoscopy, devices
R&D in Transition
Pharm Exec
Monday, January 20, 2014 - 2:49pm
tags:
R&D
Can JNJ Keep the Earnings Streak Alive?
Yahoo/Zacks.com
Monday, January 20, 2014 - 2:47pm
tags:
JNJ, earnings
Apples To Apples: Organovo Vs. Repligen
Seeking Alpha
Monday, January 20, 2014 - 2:46pm
tags:
Organovo, Repligen, bio-ink, Orencia
What’s In Store for Biotechs at this Year’s CEO & Investor Conference
BIOtechNOW
Monday, January 20, 2014 - 11:38am
tags:
biotech, BIO CEO Conference
Auxilium Pharmaceuticals (AUXL) in Focus: Stock Up 6.1%
Yahoo/Zacks.com
Monday, January 20, 2014 - 11:16am
tags:
Auxilium
Johnson & Johnson: Third Time’s Not the Charm for Expanded Xarelto Approval
Wall St Cheat Sheet
Monday, January 20, 2014 - 11:11am
tags:
JNJ, Xarelto, bloodthinners, FDA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.